Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Discover world index performance examples to understand how major benchmarks behave across regions and periods. This primer helps investors compare scales and draw quick insights.
21,743 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Two blue chips face opposite paths as rates stay high and consumer patterns shift. McDonald’s shows earnings growth w...
Investors often see a mixed day after defense-news headlines. This deep dive explains the kratos defense stock drop, ...
When a company’s top legal officer discloses a stock sale, investors pay attention. This guide explains how to read i...
A clear, investor-focused read on what The Trade Desk's Q1 2026 results mean for 2026. Discover growth drivers, margi...
When an asset manager sells million shares of a popular bond ETF, it can signal shifts in liquidity and portfolio str...
The (feam) 2026 earnings call offers more than numbers. It reveals management’s strategy, how FEAM is navigating cost...
Palantir’s CEO has shifted away from traditional earnings calls, instead sending quarterly shareholder letters that m...
In a market where dividends among healthcare firms can be elusive, two names stand out for investors seeking income n...
The crypto industry is cooling as funding tightens and demand wavers. Syndicate Labs shuts down amid a wave of cost c...
A leading investing author known for the stock market maestros concept argues that enduring gains come from disciplin...
NAR's REACH accelerator unveils six residential tech startups for 2026, signaling ongoing commitment to modernizing h...